Stock screenerAll disclosures →
EDGAR →
ELAB
Conviction 0HealthcareScan · Mon, Aug 10, 2026ELAB$0.8866-3.16%
ResistanceSupportVol 14Vol MA14 466.66K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.8866
Change-3.16%
Gap-0.86%
Rel volume0.00×
Avg volume864.72K
Avg $ vol894.44K
SMA 200.9800
SMA 501.22
SMA 2002.89
Price vs 50-27.30%
Price vs 200-69.34%
MA stackbearish
50/200 cross—
Supertrenddown · 1.15
RSI (14)36
MACD hist0.02
MACD cross—
Stoch %K / %D23 / 35
ADX (14)7
+DI / −DI20 / 22
RSI divergence—
MACD divergence—
ATR %+10.90%
ADR %7.07%
52w high14.00
52w low0.7055
From 52w high-93.67%
Above 52w low+25.67%
New 52w highNo
SqueezeOn · 28d
Bollinger width30.11%
%B0.18
Donchian pos14.56%
Donchian high1.16
Donchian low0.8400
AVWAP (52w high)4.07
vs AVWAP high-78.22%
AVWAP (52w low)4.05
vs AVWAP low-78.09%
OBV trendDown
Chaikin MF (20)0.04
Today vs 20d0.00×
Avg vol (14d)466.66K
Avg vol (20d)864.72K
Avg $ vol (20d)894.44K
Market cap4.03M
RS 3m (vs SPY)-63.31%
RS 6m (vs SPY)-56.90%
RS line new highNo
Trend template0/8
Technical rank4.4
1 week-2.79%
1 month-20.84%
3 months-55.22%
6 months-49.62%
1 year-52.97%
YTD-37.56%
P/E-0.52
P/B0.32
P/S6.83
P/FCF-0.63
EPS-0.4000
Div yield—
ROE-61.46%
ROA-29.76%
Debt/Eq—
Current1.45
EV/EBITDA—
Gross margin31.40%
Net margin—
Rev growth-65.54%
EPS growth-24.05%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value44.04K
Revenue681.99K
Net income-4.97M
Gross profit230.47K
Free cash flow-6.38M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.54M
Employees34
ListedTue, Nov 21, 2023
Free float1.18M
Float %99.9%
Short interest809.2K
Days to cover0.1d
Short volume75.1%
Squeeze score60 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank4.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.51
Support0.8554
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ELAB
No recent disclosed trades by Congress in ELAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ELAB · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bensler Graydon Chief Executive Officer · Options · 2026-06-01 | Grant | 450.28K | $0 | 2026-06-01 | 2026-06-03 |
Parry Jeffrey Director · Options · 2026-06-01 | Grant | 75.05K | $0 | 2026-06-01 | 2026-06-03 |
Daley Juliana Director · Options · 2026-06-01 | Grant | 75.05K | $0 | 2026-06-01 | 2026-06-02 |
Kovalyov George Director · Options · 2026-06-01 | Grant | 75.05K | $0 | 2026-06-01 | 2026-06-02 |
Braeden Lichti Director · Options · 2026-06-01 | Grant | 450.28K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in ELAB · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.